469 | Single (specified) Analyte Controls (assayed And Unassayed) | Quality Control Material (assayed And Unassayed). |
469 | Single (specified) Analyte Controls (assayed And Unassayed) | Quality Control Material (assayed And Unassayed). |
Single (Specified) Analyte Controls (Assayed And Unassayed) [34731] | 21 CFR §862.1660 🔎 |
K170678 | Beta-CrossLaps CalCheck 5 | Roche Diagnostics |
K162514 | Multichem A1c | Technopath Manufacturing |
K162173 | Elecsys CYFRA 21-1 CalCheck 5 | Roche Diagnostics |
K161874 | Audit MicroControls Linearity DROP LQ Blood Glucose | AALTO SCIENTIFIC, LTD. |
K161526 | LIAISON CMV IgM Serum Control Set | DiaSorin Inc. |
K161522 | LIAISON EBV IgM Serum Control Set | DiaSorin Inc. |
K161082 | IDS-iSYS 17-OH Progesterone Control Set, IDS-iSYS 17-OH Progesterone Calibration Verifiers | IMMUNODIAGNOSTIC SYSTEMS LTD. |
K152117 | Dropper HsCRP High Sensitivity CRP Control | Quantimetrix Corporation |
K151742 | Contour Next Control Solution | BAYER HEALTHCARE |
K150955 | Elecsys Progesterone III Cal Check 5 | ROCHE DIAGNOSTICS |
K150132 | IMMULITE IGF Control Module, IMMULITE Gastrin Control Module | Siemens Healthcare Diagnostics |
K143687 | ADVIA Centaur Follicle Stimulating Hormone (FSH) Master Curve Material, ADVIA Centaur FT4 Master Curve Material, ADVIA Centaur T4 Master Curve Material, ADVIA Centaur T3 Master Curve Material | SIEMENS HEALTHCARE DIAGNOSTICS, INC. |
K143680 | ADVIA Centaur IgE Master Curve Material | SIEMENS HEALTHCARE DIAGNOSTICS, INC. |
K143636 | IMMULITE 2000 Androstenedione Calibration Verification Material, IMMULITE 2000 Troponin I Calibration Verification Material | SIEMENS HEALTHCARE DIAGNOSTICS, INC. |
K143639 | IMMULITE 2000 CEA Calibration Verification Material | Siemens Healthcare Diagnostics |
00389167262101 | Single (Specified) Analyte Controls (Assayed And Unassayed) |
00389154000549 | Single (Specified) Analyte Controls (Assayed And Unassayed) |
00389154000716 | Single (Specified) Analyte Controls (Assayed And Unassayed) |
00389154000495 | Single (Specified) Analyte Controls (Assayed And Unassayed) |
20385543764027 | Single (Specified) Analyte Controls (Assayed And Unassayed) |
00385480547901 | Single (specified) analyte controls (assayed and unassayed) |
00385480528559 | Single (specified) analyte controls (assayed and unassayed) |
00385480475549 | Single (specified) analyte controls (assayed and unassayed) |
00385480475532 | Single (specified) analyte controls (assayed and unassayed) |
10385480467992 | Single (specified) analyte controls (assayed and unassayed) |
10385480458860 | Single (specified) analyte controls (assayed and unassayed) |
00385480440370 | Single (specified) analyte controls (assayed and unassayed) |
00385480439237 | Single (specified) analyte controls (assayed and unassayed) |
00385480439220 | Single (specified) analyte controls (assayed and unassayed) |
00385480439213 | Single (specified) analyte controls (assayed and unassayed) |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-23 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-18 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-18 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-18 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-16 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-03-04 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-02-24 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-02-07 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-02-06 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-02-04 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-02-04 |
BIOPLEX 2200 | BIO-RAD LABORATORIES, INC | 2020-02-04 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-01-22 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-01-15 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-01-13 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2020-01-03 |
CONTOUR | ASCENSIA DIABETES CARE US INC. | 2020-01-03 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-12-17 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-12-06 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-11-25 |
ROM PLUS RUPTURE MEMBRANES TEST | CLINICAL INNOVATIONS, LLC | 2019-11-21 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-11-21 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-11-20 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-11-20 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-11-15 |
ARCHITECT BNP CONTROLS | ABBOTT GERMANY | 2019-11-08 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-31 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-25 |
CONTOUR NEXT ONE | ASCENSIA DIABETES CARE US INC. | 2019-10-25 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-24 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-24 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-02 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-02 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-10-01 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-27 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-27 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-25 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-25 |
ARCHITECT BNP CONTROLS | ABBOTT GERMANY | 2019-09-20 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-02 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-02 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-09-02 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-08-23 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-08-12 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-08-09 |
ARCHITECT BNP CONTROLS | ABBOTT GERMANY | 2019-08-07 |
ARCHITECT BNP CONTROLS | ABBOTT GERMANY | 2019-08-07 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-08-01 |
ARCHITECT BNP CONTROLS | ABBOTT LABORATORIES | 2019-07-22 |
CONTOUR NEXT | ASCENSIA DIABETES CARE US INC. | 2019-07-19 |